The deletion of Cdkn2a, a mutation that frequently occurs in all known melanoma genetic subtypes, was found associated with the activation of mTORC2/Akt signaling although the precise mechanisms underlying this event where not fully elucidated. This evidence concerns the gene CDKN2A and melanoma.